These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11548225)

  • 61. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.
    Bruyere O; Reginster JY
    Drugs Aging; 2007; 24(7):573-80. PubMed ID: 17658908
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis.
    Bucsi L; Poór G
    Osteoarthritis Cartilage; 1998 May; 6 Suppl A():31-6. PubMed ID: 9743817
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal.
    Tapadinhas MJ; Rivera IC; Bignamini AA
    Pharmatherapeutica; 1982; 3(3):157-68. PubMed ID: 7134225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. No effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trial.
    Wilkens P; Storheim K; Scheel I; Berg L; Espeland A
    J Negat Results Biomed; 2012 Aug; 11():13. PubMed ID: 22900984
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study.
    Roemer FW; Kwoh CK; Hannon MJ; Green SM; Jakicic JM; Boudreau R; Crema MD; Moore CE; Guermazi A
    Arthritis Rheum; 2012 Jun; 64(6):1888-98. PubMed ID: 22213129
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity.
    Ali AA; Lewis SM; Badgley HL; Allaben WT; Leakey JE
    Arch Biochem Biophys; 2011 Jun; 510(1):11-8. PubMed ID: 21466783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.
    Jackson CG; Plaas AH; Sandy JD; Hua C; Kim-Rolands S; Barnhill JG; Harris CL; Clegg DO
    Osteoarthritis Cartilage; 2010 Mar; 18(3):297-302. PubMed ID: 19912983
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of oral glucosamine on joint health: is a change in research approach needed?
    Block JA; Oegema TR; Sandy JD; Plaas A
    Osteoarthritis Cartilage; 2010 Jan; 18(1):5-11. PubMed ID: 19733270
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.
    Kawasaki T; Kurosawa H; Ikeda H; Kim SG; Osawa A; Takazawa Y; Kubota M; Ishijima M
    J Bone Miner Metab; 2008; 26(3):279-87. PubMed ID: 18470670
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials.
    Rovati LC; Pavelka K; Giacovelli G; Reginster JY
    Osteoarthritis Cartilage; 2006; 14 Suppl A():A14-8. PubMed ID: 16678450
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
    Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
    J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacotherapy for patellofemoral pain syndrome.
    Heintjes E; Berger MY; Bierma-Zeinstra SM; Bernsen RM; Verhaar JA; Koes BW
    Cochrane Database Syst Rev; 2004; 2004(3):CD003470. PubMed ID: 15266488
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee.
    Grove ML
    J Rheumatol; 2004 Apr; 31(4):826; author reply 826-7. PubMed ID: 15095742
    [No Abstract]   [Full Text] [Related]  

  • 74. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies.
    Bruyere O; Pavelka K; Rovati LC; Deroisy R; Olejarova M; Gatterova J; Giacovelli G; Reginster JY
    Menopause; 2004; 11(2):138-43. PubMed ID: 15021442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study.
    Nguyen P; Mohamed SE; Gardiner D; Salinas T
    Cranio; 2001 Apr; 19(2):130-9. PubMed ID: 11842864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glucosamine.
    Barclay TS; Tsourounis C; McCart GM
    Ann Pharmacother; 1998 May; 32(5):574-9. PubMed ID: 9606479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical research in osteoarthritis: design and results of short-term and long-term trials with disease-modifying drugs.
    Rovati LC
    Int J Tissue React; 1992; 14(5):243-51. PubMed ID: 1300310
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A multi-central, randomized, controlled clinical trial of glucosamine hydrochloride/sulfate in the treatment of knee osteoarthritis].
    Qiu GX; Weng XS; Zhang K; Zhou YX; Lou SQ; Wang YP; Li W; Zhang H; Liu Y
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3067-70. PubMed ID: 16324409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial.
    Chopra A; Saluja M; Tillu G; Sarmukkaddam S; Venugopalan A; Narsimulu G; Handa R; Sumantran V; Raut A; Bichile L; Joshi K; Patwardhan B
    Rheumatology (Oxford); 2013 Aug; 52(8):1408-17. PubMed ID: 23365148
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol.
    Scholtissen S; Bruyère O; Neuprez A; Severens JL; Herrero-Beaumont G; Rovati L; Hiligsmann M; Reginster JY
    Int J Clin Pract; 2010 May; 64(6):756-62. PubMed ID: 20518951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.